The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the U.N.-backed effort to supply poorer countries.
Vaccine availability has been improving in poorer regions recently, but logistical problems persist.
The company, struggling to scale up production, also has delayed delivery to other countries, including some in the European Union. COVAX is supposed to receive more than 1 billion Novavax doses. Gavi suggested part of the delay is that the Novavax vaccine wasn’t authorized by WHO until December. Gavi said it planned to allocate Novavax in the future and was “in close touch with the manufacturer and expects the supply to be available for delivery when countries need it.”
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
A hidden immune feature may have spared unvaccinated people from COVID-19 infectionsA team of researchers at the University of Gothenburg identified IgA in the respiratory tracts of several of the personnel who didn't catch COVID-19.
Lire la suite »
Luke Combs Tests Positive for COVID-19, Won’t Be Performing at CMT Music AwardsAfter testing positive for COVID-19, Luke Combs will not be performing at the CMT Music Awards.
Lire la suite »
As Covid-19 cases fall and masks come off, flu cases are risingAfter circulating at nearly nonexistent levels last year, influenza is increasing in most of the United States, according to the CDC
Lire la suite »
Cornell University reports indications of 'substantial prevalence' of COVID-19 on campusCornell recorded 515 positive COVID-19 infections among students, staff, and faculty, according to data from the university.
Lire la suite »
With Sharp Drop in Demand, Community-Based COVID-19 Testing Sites to End Operations March 31Illinois will close its community, free COVID-19 testing sites within the next week. The Illinois Department of Public Health cites a “sharp increase in demand” that dropped “precipitously in recent weeks” as its reason for closing the testing locations, as well as an “anticipated end of federal funding.”
Lire la suite »
Study: Aspirin early on could be effective for COVID-19 patientsScientists from George Washington University looked at medical data of more than 110,000 U.S. patients from 64 hospitals.
Lire la suite »